Trials / Recruiting
RecruitingNCT05623956
Proteomics in Small Cell Lung Cancer
Circulating Metabolites and Tumor-derived Extravesicular Proteins in Small Cell Lung Cancer
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 50 (estimated)
- Sponsor
- Aalborg University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The aim of this study is to gather insight into tumor-derived circulating extracellular vesicles-proteins in patients with newly diagnosed small cell lung cancer.
Detailed description
The study will include 50 patients with newly diagnosed SCLC, referred to systemic antineoplastic treatment at the Dept. of Oncology, Aalborg University Hospital and blood samples from 50 healthy blood donors. The blood samples from SCLC patients will be collected before chemotherapy with Carboplatin and Etoposide and after 2 cycles of chemotherapy. Imaging will be performed at the Dept. of Radiology, Aalborg University Hospital before chemotherapy and after 3 cycles of the treatment.
Conditions
Timeline
- Start date
- 2023-03-01
- Primary completion
- 2025-12-01
- Completion
- 2025-12-01
- First posted
- 2022-11-21
- Last updated
- 2025-01-31
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT05623956. Inclusion in this directory is not an endorsement.